Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
about
Recent advances in treatment of severe primary immunodeficienciesStem cell transplantation for primary immunodeficiency diseases: the North American experienceLong-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.History and current status of newborn screening for severe combined immunodeficiency.Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington StateUnrelated Hematopoietic Cell Transplantation in a Patient with Combined Immunodeficiency with Granulomatous Disease and Autoimmunity Secondary to RAG Deficiency.Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies.Stem cell transplantation for the treatment of immunodeficiency in children: current status and hopes for the future.Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsoPrimary Immune Deficiency Treatment Consortium (PIDTC) update.The Primary Immune Deficiency Treatment Consortium: how can it improve definitive therapy for PID?Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease.Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.The effects of prenatal genetic analysis on fetuses born to carrier mothers with primary immunodeficiency diseases.Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell TransplantationUnconditioned unrelated donor bone marrow transplantation for IL7Rα- and Artemis-deficient SCID.Long term outcomes of severe combined immunodeficiency: therapy implications.A Practical Approach to Newborn Screening for Severe Combined Immunodeficiency Using the T Cell Receptor Excision Circle Assay.Hematopoietic cell transplantation in primary immunodeficiency - conventional and emerging indications.Cytoreductive conditioning for severe combined immunodeficiency--help or hindrance?Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID.B cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.
P2860
Q26766170-6CC24748-5892-4140-AAC4-4C02C4C245E3Q26827162-46EA723F-253E-4A84-AF02-AEC86FDBE3F4Q33434039-61C914C7-13FC-483C-AE70-F28B49A1A53CQ35613205-AB9EAA42-7F33-4095-BA29-64EAE4052FB4Q36269199-8DADC876-330B-4308-A743-10DDB203AC27Q36839938-5517E0D0-777F-40FA-B500-E85FE9EED28DQ37618790-920619B6-A1D6-41EB-98FC-E100210F06BDQ38519892-2D507405-7C5A-4C3F-BC0B-BA59A89D0149Q38735833-9C7193F7-3ABE-4F02-A01F-15660859F898Q38772827-7D7F1A5F-546C-481D-8232-F4FE0D8F1582Q38855061-E63153B9-CF9A-46B5-BF7E-A9A9A333E810Q38907589-3C30B2DB-B259-48CC-94DB-595E781DDA2CQ38922397-133DF2DB-BB97-42D3-8241-2F9916490962Q40375767-C5C9E56E-AE25-46A4-958C-0DD55BAEC83CQ40545682-BF5BDE85-868E-4521-B84F-9C5F35AD3410Q40800083-9A973E9A-1060-409D-B2DA-25C6314A8649Q42859472-29F13A34-27EE-45E8-9A79-9AE709F0281FQ44575275-6C6D8175-3D25-4BAE-907B-19F6CD70A2FCQ45872036-A3DFC4D3-4989-4A73-9BBE-6B86FA5BB1EAQ47131379-E98567E6-DCC0-4F25-B32C-CA2F93554879Q47210347-41FD0458-3E5E-4A7A-A21F-BA655178A84AQ48027176-6A4B40D3-EECA-499F-99A3-72EE186E04FBQ52602018-E84837CC-B63E-486D-9250-21108E3F0ECBQ53819932-36CAB269-2938-4316-B491-81E5D46D10BDQ55334301-2F537856-15B8-441B-9A7F-97E51D76BCC9
P2860
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@ast
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@en
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@nl
type
label
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@ast
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@en
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@nl
prefLabel
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@ast
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@en
Comparison of outcomes of hema ...... ere combined immunodeficiency.
@nl
P2093
P2860
P1476
Comparison of outcomes of hema ...... vere combined immunodeficiency
@en
P2093
Amel Hassan
Andrew R Gennery
Arjan C Lankester
Christopher C Dvorak
David F Crawford
Jacob H Bleesing
Jake Hassid
James A Connelly
Jeffrey H Davis
Luigi D Notarangelo
P2860
P304
935-943.e15
P356
10.1016/J.JACI.2014.06.021
P407
P577
2014-08-07T00:00:00Z